Neonatology Practice Questions

Q: Which of the following is considered a normal finding in a term neonate?

All of the above. In neonatology, it is crucial to distinguish between physiological variations and pathological conditions. All the options listed are common, benign findings in a healthy term neonate that require no intervention. **Detailed Breakdown:** * **Erythema Toxicum Neonatorum (Option A):** This is a benign, self-limiting rash appearing in up to 50% of term newborns, usually within the first 24–48 hours. It presents as erythematous macules with central pale yellow/white papules or pustules. **High-yield fact:** A Tzanck smear of the pustule reveals **eosinophils**, distinguishing it from transient neonatal pustular melanosis (which shows neutrophils). * **Epstein’s Pearls (Option B):** These are small (1–3 mm), white-yellow epithelial cysts found on the **hard palate** near the median raphe. They are developmental remnants of trapped epithelium and typically resolve spontaneously within a few weeks. * **Subconjunctival Hemorrhages (Option C):** These are common following vaginal delivery due to the sudden increase in intrathoracic and venous pressure as the baby passes through the birth canal. They appear as bright red patches on the sclera, are asymptomatic, and resolve without treatment within 1–2 weeks. **Clinical Pearls for NEET-PG:** * **Milium:** Tiny white sebaceous cysts on the nose/cheeks (keratin-filled). * **Mongolian Spots:** Slate-gray/blue macules typically over the lumbosacral area; caused by arrested melanocyte migration. * **Molding:** Temporary alteration in head shape due to overlapping of cranial bones during labor; resolves in 2–3 days. * **Vaginal Bleeding:** "Pseudomenses" in female neonates is normal due to withdrawal of maternal estrogen.

Q: What is the primary cause of hyaline membrane disease?

Surfactant deficiency. **Explanation:** **Hyaline Membrane Disease (HMD)**, also known as Respiratory Distress Syndrome (RDS), is primarily caused by **surfactant deficiency**. Surfactant, produced by Type II pneumocytes, reduces surface tension within the alveoli. Without adequate surfactant, surface tension increases, leading to widespread alveolar collapse (atelectasis) at the end of expiration. This results in poor gas exchange, hypoxia, and the formation of proteinaceous "hyaline membranes" within the airspaces. **Analysis of Options:** * **A. Prematurity:** While prematurity is the most significant **risk factor** for HMD (as surfactant production typically matures after 34 weeks), it is not the *pathophysiological cause*. The disease itself is a direct result of the missing biochemical substance (surfactant). * **B. Oxygen Toxicity:** This is a potential **complication** of treatment (leading to Bronchopulmonary Dysplasia or Retinopathy of Prematurity) rather than the cause of HMD. * **C. Alveolar Inflammation:** This is characteristic of pneumonia or meconium aspiration syndrome, not the primary mechanism of HMD, which is non-inflammatory atelectasis. **High-Yield Clinical Pearls for NEET-PG:** * **Lecithin/Sphingomyelin (L/S) Ratio:** A ratio **>2:1** in amniotic fluid indicates fetal lung maturity. * **X-ray Findings:** Classic "Ground glass appearance" with air bronchograms and low lung volumes. * **Prevention:** Antenatal corticosteroids (e.g., Dexamethasone or Betamethasone) given to the mother significantly reduce the risk. * **Management:** The standard of care includes **CPAP** and exogenous surfactant replacement (e.g., Poractant alfa) via the **INSURE** technique (Intubate-Surfactant-Extubate).

Q: A preterm neonate with hyaline membrane disease needs to be treated with:

Surfactant. ### Explanation **Correct Answer: D. Surfactant** **Medical Concept:** Hyaline Membrane Disease (HMD), also known as Respiratory Distress Syndrome (RDS), is primarily caused by a **deficiency of pulmonary surfactant** in preterm neonates. Surfactant (produced by Type II pneumocytes) reduces alveolar surface tension, preventing alveolar collapse at the end of expiration. In its absence, the lungs become stiff (low compliance), leading to diffuse atelectasis and impaired gas exchange. Therefore, the definitive treatment for a neonate with HMD is **Exogenous Surfactant Replacement Therapy** (e.g., Poractant alfa or Beractant) administered via the endotracheal tube. **Why the other options are incorrect:** * **A & B (Dexamethasone/Betamethasone):** These are **antenatal corticosteroids**. They are administered to the *mother* (not the neonate) at risk of preterm delivery to accelerate fetal lung maturity and prevent HMD. Once the neonate is born with HMD, they are not the primary treatment. * **C (Hydrocortisone):** This is typically used in neonates for refractory hypotension or adrenal insufficiency, but it has no role in the acute management of HMD. **High-Yield Clinical Pearls for NEET-PG:** * **Radiology:** The classic X-ray finding in HMD is a **"Ground Glass Appearance"** with prominent air bronchograms. * **L/S Ratio:** A Lecithin/Sphingomyelin ratio of **<2:1** in amniotic fluid indicates fetal lung immaturity. * **Administration:** Surfactant is often given via the **INSURE** technique (Intubation, Surfactant, and Extubation to CPAP). * **Prevention:** A single course of antenatal Betamethasone (12 mg, 2 doses 24 hours apart) is the gold standard for prevention.

Q: At what age is physiological jaundice typically observed in a newborn?

Within the first week of life. **Explanation:** Physiological jaundice is a common, non-pathological condition occurring in approximately 60% of term and 80% of preterm neonates. It occurs due to a transient imbalance between bilirubin production (high RBC turnover) and bilirubin clearance (immature hepatic glucuronosyltransferase enzyme). **Why Option B is correct:** Physiological jaundice typically appears **after 24 hours** of life, peaks between days 3–5 in term infants (days 5–7 in preterm), and usually resolves by the end of the **first week** (or 14 days in preterm). Therefore, it is characteristically observed within the first week of life. **Why other options are incorrect:** * **Option A (At birth):** Jaundice appearing at birth or within the first 24 hours is **always pathological**. Common causes include ABO/Rh incompatibility or intrauterine infections. * **Option C & D (One month/year):** Jaundice at these ages is abnormal. Prolonged jaundice (beyond 2 weeks) requires investigation for cholestasis (e.g., Biliary Atresia) or metabolic disorders. **NEET-PG High-Yield Pearls:** 1. **Kramer’s Rule:** Used for clinical assessment of jaundice progression (Cephalo-caudal progression). 2. **Pathological Jaundice Criteria:** Appears 5 mg/dL/day, or total bilirubin exceeds 15 mg/dL. 3. **Treatment:** Phototherapy is the first line; it converts bilirubin into water-soluble **lumirubin** via structural isomerization. 4. **Breast Milk Jaundice:** Typically starts after the first week (day 7–10) and can last for several weeks, unlike physiological jaundice.

Q: An infant has an APGAR score of 6 at 5 minutes of life. What is the interpretation of this score?

Moderate asphyxia. **Explanation:** The APGAR score is a rapid clinical assessment tool used at 1 and 5 minutes after birth to evaluate a neonate’s transition to extrauterine life. It assesses five parameters: Heart Rate, Respiratory Effort, Muscle Tone, Reflex Irritability, and Color. **Why Option B is Correct:** The interpretation of the APGAR score is categorized as follows: * **7 to 10:** Normal/Excellent (No depression) * **4 to 6:** **Moderate Asphyxia** (Mild to moderate depression) * **0 to 3:** Severe Birth Asphyxia (Severe depression) A score of 6 at 5 minutes falls squarely into the **Moderate Asphyxia** category, indicating that the infant requires stimulation and potentially supplemental oxygen or bag-mask ventilation, but is not in a state of terminal collapse. **Why Other Options are Incorrect:** * **Option A:** A score of 7 or above is considered normal. A score of 6 indicates the infant is struggling and requires intervention. * **Option C:** Severe asphyxia is reserved for scores between 0 and 3. These infants usually require aggressive resuscitation (intubation/chest compressions). * **Option D:** While a score of 6 requires *intervention*, the term "immediate resuscitation" in neonatal protocols usually refers to the 1-minute score or infants with scores <3. Furthermore, the question asks for the **interpretation** (diagnosis/category) rather than the management step. **High-Yield Clinical Pearls for NEET-PG:** * **Most Objective Parameter:** Heart Rate. * **Least Reliable/First to disappear:** Color (Acrocyanosis is common and normal). * **Prognostic Value:** The 5-minute and 10-minute scores are better predictors of long-term neurological outcomes than the 1-minute score. * **Limitation:** APGAR score alone does **not** diagnose birth asphyxia; it must be correlated with umbilical cord blood pH and clinical signs of encephalopathy (HIE).

Q: Which is the commonest abdominal mass in a neonate?

Neuroblastoma. **Explanation:** In neonates, the majority (approximately 55-60%) of abdominal masses are of **renal origin**. However, when evaluating the options provided for the most common **neoplastic (malignant)** abdominal mass or a specific pathological entity in this context, **Neuroblastoma** is the correct choice. * **Neuroblastoma (Correct):** It is the most common malignant tumor of childhood and the most common abdominal malignancy in the neonatal period. It frequently presents as a firm, irregular mass that often crosses the midline. In neonates, it may present as "Blueberry muffin" spots (skin metastases) or massive hepatomegaly (Pepper syndrome). * **Wilms’ Tumor (Incorrect):** While it is the most common primary renal malignancy in children, it is **rare in the neonatal period**. The peak incidence is between 2 to 5 years of age. * **Polycystic Kidney (Incorrect):** Autosomal Recessive Polycystic Kidney Disease (ARPKD) can present with bilateral flank masses in a neonate, but it is a congenital cystic disease rather than a solid tumor. Statistically, multicystic dysplastic kidney (MCDK) is the most common *non-malignant* renal mass, but it is not listed here. * **Rhabdomyosarcoma (Incorrect):** This is a soft tissue sarcoma that can occur in the genitourinary tract, but it is significantly less common than neuroblastoma in the neonatal age group. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause of neonatal abdominal mass:** Multicystic Dysplastic Kidney (MCDK) – *Non-malignant*. * **Most common neonatal malignancy:** Neuroblastoma. * **Most common renal malignancy in neonates:** Congenital Mesoblastic Nephroma (not Wilms'). * **Key distinction:** Neuroblastoma often crosses the midline and may have calcifications on X-ray/CT, whereas Wilms’ tumor usually does not cross the midline.

Q: The APGAR score includes which of the following parameters except?

Blood pressure. The APGAR score is a rapid clinical assessment tool used at 1 and 5 minutes after birth to evaluate a newborn's physical condition and the need for immediate resuscitation. **Explanation of the Correct Answer:** **C. Blood Pressure** is the correct answer because it is **not** a component of the APGAR score. In a delivery room setting, measuring blood pressure is time-consuming and requires specialized equipment, making it impractical for a rapid 60-second assessment of a neonate’s transition to extrauterine life. **Explanation of Incorrect Options:** The APGAR acronym stands for: * **A - Appearance (Skin Color):** Assessing for cyanosis or pallor. * **P - Pulse (Heart Rate):** The most important prognostic indicator. (**Option A**) * **G - Grimace (Reflex Irritability):** Response to stimulation (e.g., suctioning). * **A - Activity (Muscle Tone):** Degree of flexion and movement. (**Option B**) * **R - Respiration (Breathing Effort):** Evaluated by the quality of the cry or chest excursions. (**Option D**) **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** Routinely performed at **1 and 5 minutes**. If the 5-minute score is <7, it is repeated every 5 minutes up to 20 minutes. * **Scoring:** Each parameter is scored 0, 1, or 2 (Total score: 0–10). * **Interpretation:** 7–10 is normal; 4–6 is moderately depressed; 0–3 is severely depressed. * **Prognostic Value:** The APGAR score does **not** predict long-term neurological outcomes or cerebral palsy; it primarily reflects the effectiveness of resuscitation efforts. * **Sequence of Disappearance:** In neonatal distress, the parameters usually disappear in the order of: Color → Respiration → Muscle Tone → Reflex Irritability → Heart Rate.

Q: Meconium is excreted by a newborn till which day?

3rd. **Explanation:** The transition of stool in a newborn follows a predictable chronological pattern based on the initiation of enteral feeding and the clearance of intrauterine debris. * **Correct Answer (B - 3rd Day):** Meconium is the first stool of a newborn, composed of amniotic fluid, mucus, lanugo, bile, and epithelial cells. In a healthy, term neonate, meconium is typically passed within the first 24–48 hours. By the **3rd day**, the stool begins to transition from the thick, tarry, black-green meconium to "transitional stools" (brownish-green/yellow), marking the end of pure meconium excretion. **Analysis of Incorrect Options:** * **A (2nd Day):** While most infants pass their *first* stool by day 2, the excretion of meconium continues until the gastrointestinal tract is cleared, usually extending into the 3rd day. * **D (4th Day):** By the 4th day, stools should ideally be "milk stools" (yellow and mustard-like in breastfed infants). Persistent meconium beyond the 4th day may indicate inadequate milk intake or underlying pathology. * **C (6th Day):** This is pathologically late. Prolonged meconium passage suggests intestinal obstruction or dysmotility. **High-Yield Clinical Pearls for NEET-PG:** * **Delayed Meconium (>48 hours):** Always rule out **Hirschsprung disease**, **Meconium ileus** (associated with Cystic Fibrosis), or **Anorectal malformations**. * **Meconium Plug Syndrome:** Often seen in infants of diabetic mothers or those exposed to magnesium sulfate. * **Stool Color Evolution:** Meconium (Day 1-2) → Transitional (Day 3-4) → Milk Stool (Day 5+). * **Failure to pass meconium** is the earliest clinical sign of Hirschsprung disease in 90% of cases.

Q: Physiological jaundice of the newborn may be managed by all of the following except?

Phenytoin sodium. **Explanation:** Physiological jaundice is a common, self-limiting condition in neonates caused by the transient inability of the immature liver to conjugate bilirubin. While most cases require only observation, certain pharmacological and physical interventions can be used to manage rising bilirubin levels. **Why Phenytoin sodium is the correct answer:** Phenytoin is **not** used in the management of neonatal jaundice. In fact, phenytoin is known to be metabolized by the liver and does not induce the enzymes responsible for bilirubin conjugation in a clinically useful way for neonates. Conversely, **Phenobarbital** (not Phenytoin) is the drug used in specific cases (like Crigler-Najjar Type II) because it induces the enzyme *UDP-glucuronosyltransferase*, which enhances bilirubin conjugation. **Analysis of other options:** * **Metalloporphyrins (e.g., Tin-mesoporphyrin):** These are competitive inhibitors of the enzyme *Heme Oxygenase*. They work by blocking the rate-limiting step of heme degradation into biliverdin, thereby preventing the production of bilirubin. * **Phototherapy:** This is the gold standard and most common treatment. It uses light energy (ideally blue-green spectrum, 460-490 nm) to convert unconjugated bilirubin into water-soluble isomers (**lumirubin** and photobilirubin) that can be excreted in bile and urine without conjugation. **NEET-PG High-Yield Pearls:** * **Lumirubin:** The structural isomer formed during phototherapy; its formation is irreversible and it is the most important pathway for bilirubin excretion. * **Phenobarbital:** Takes 3–7 days to act; it is generally not used for acute physiological jaundice but may be used in chronic cholestasis or Crigler-Najjar syndrome. * **Bronze Baby Syndrome:** A complication of phototherapy occurring in infants with conjugated hyperbilirubinemia.

Question 1

Which of the following is considered a normal finding in a term neonate?

Accepted Answer

All of the above

Answer

Erythema toxicum

Answer

Epstein's pearls

Answer

Subconjunctival hemorrhages

Question 2

What is the primary cause of hyaline membrane disease?

Accepted Answer

Surfactant deficiency

Answer

Prematurity

Answer

Oxygen toxicity

Answer

Alveolar inflammation

Question 3

A preterm neonate with hyaline membrane disease needs to be treated with:

Accepted Answer

Surfactant

Answer

Dexamethasone

Answer

Betamethasone

Answer

Hydrocortisone

Question 4

At what age is physiological jaundice typically observed in a newborn?

Accepted Answer

Within the first week of life

Answer

At birth

Answer

At one month of age

Answer

At one year of age

Question 5

An infant has an APGAR score of 6 at 5 minutes of life. What is the interpretation of this score?

Accepted Answer

Moderate asphyxia

Answer

Normal infant

Answer

Severe birth asphyxia

Answer

Requires immediate resuscitation

Question 6

Which is the commonest abdominal mass in a neonate?

Accepted Answer

Neuroblastoma

Answer

Wilm's tumor

Answer

Polycystic kidney

Answer

Rhabdomyosarcoma

Question 7

The APGAR score includes which of the following parameters except?

Accepted Answer

Blood pressure

Answer

Heart rate

Answer

Muscle tone

Answer

Breathing effort

Question 8

Meconium is excreted by a newborn till which day?

Accepted Answer

3rd

Answer

2nd

Answer

6th

Answer

4th

Question 9

Physiological jaundice of the newborn may be managed by all of the following except?

Accepted Answer

Phenytoin sodium

Answer

Metalloporphyrin

Answer

Phototherapy

Answer

None of the above

Question 10

A mother is holding her newborn baby in the hospital bed just a few hours after giving birth. The mother becomes alarmed when her baby begins to have difficulty in breathing and she rings for help. Upon examination, the baby is in severe respiratory distress with a barrel-shaped chest, scaphoid-shaped abdomen, and absence of breath sounds on the left side. A chest radiograph reveals air/fluid containing bowel in the left-side hemithorax, no visible aerated lung on the left side, contralateral displacement of the heart and other mediastinal structures, compression of the contralateral lung, and reduced size of the abdomen. Which of the following is the most likely diagnosis?

Accepted Answer

Congenital Diaphragmatic Hernia

Answer

Esophageal Hiatal hernia

Answer

Infantile Hypertrophic Pyloric Stenosis

Answer

Tracheoesophageal fistula (TEF)

Neonatology — MCQs

Neonatology — MCQs

On this page

Practice by Chapter

Want unlimited practice?